JMF
DTIL icon

Johnson Midwest Financial’s Precision BioSciences DTIL Stock Holding History

Johnson Midwest Financial’s Portfolio DTIL Stock Details DTIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-28
Closed -$10K – 307
2021
Q3 		$10K Hold
28
– – 0.01% 185
2021
Q2 		$11K Hold
28
– – 0.01% 165
2021
Q1 		$9K Hold
28
– – 0.01% 169
2020
Q4 		$7K Buy
+28
New +$6.86K 0.01% 186

Other funds holding DTIL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
OMC
OUP Management Company Bala Cynwyd, Pennsylvania $44.5M AUM 55.11% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

Johnson Midwest Financial's DTIL Position: Q4 2021 in Review

Johnson Midwest Financial sold out of Precision BioSciences (DTIL) in Q4 2021, closing a stake of 28 shares — an estimated $10K sold.

Johnson Midwest Financial first reported a position in DTIL in Q4 2020 and held it in 4 quarters. The position peaked at $11K in Q2 2021. 134 funds tracked by Wall St. Rank hold DTIL as of Q4 2021.

  • Johnson Midwest Financial reported no remaining Precision BioSciences position as of Q4 2021 after selling out during the quarter.
  • Johnson Midwest Financial sold 28 Precision BioSciences shares in Q4 2021, an estimated $10K.
  • Johnson Midwest Financial first reported a position in Precision BioSciences in Q4 2020 and held it in 4 quarters.
  • Johnson Midwest Financial's Precision BioSciences position peaked at $11K in Q2 2021.
  • 134 funds tracked by Wall St. Rank held Precision BioSciences as of Q4 2021.

Based on Johnson Midwest Financial's 13F filing for Q4 2021, filed 26 Jan 2022.